XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Acquisitions (Tables)
 6 Months Ended
Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of the Amounts Recognized for Assets Acquired and Liabilities Assumed
Estimated Fair Value at May 23, 2024
Cash$2.3 
Goodwill(1)
816.5
Property and equipment108.5
Other assets and liabilities, net(0.3)
Acquisition date fair value of consideration transferred 927.0 
Less:
Cash acquired(2.3)
Cash paid, net of cash acquired$924.7 
(1) The goodwill recognized from this acquisition is primarily attributable to the synergies between the manufacturing capabilities of the site and our products as well as the assembled workforce of the site, which is deductible for tax purposes.
The following table summarizes the preliminary amounts recognized for assets acquired and liabilities assumed as of the acquisition date:
Estimated Fair Value at December 27, 2023
Cash$302.7 
Acquired in-process research and development (IPR&D)
196.0
Goodwill (1)
859.1
Other assets and liabilities, net(19.3)
Acquisition date fair value of consideration transferred 1,338.5 
Less:
Cash acquired(302.7)
Cash paid, net of cash acquired$1,035.8 
(1) The goodwill recognized from this acquisition is primarily attributable to the radiopharmaceutical discovery, development, and manufacturing capabilities and the assembled workforce for POINT, which is not deductible for tax purposes.